Paul Stuka
CIK 1528577 · last filed 2026-09-23
Paul Stuka is a corporate insider who has filed 51 SEC Form 4 insider transactions across 4 companies since 2013. The most recent filing, for NSPR, was dated Sep 23, 2026. Across all open-market trades the lifetime net is +$1.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $491.2K across reported positions. 3 SEC filings were submitted jointly with OSIRIS INVESTMENT PARTNERS LP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NSPR price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ONE LIBERTY SQUARE, 5TH FLOOR
BOSTON, MA 02109
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NSPR | Director | 1,091,575 | $0.45 | $491.2K | $1.19M | 35 | 2026-09-23 |
| InspireMD, Inc. (NSPRZ) Delisted | Director | 115,854 | $0.01 | $1.0K | $260.3K | 6 | 2021-12-02 |
| InspireMD, Inc. (NSPR.WS.B) Delisted | Director | 256,352 | $0.03 | $7.7K | -$12 | 3 | 2020-09-02 |
| InspireMD, Inc. (NSPR.WS) Delisted | Director | — | $0.05 | — | $0 | 1 | 2016-12-08 |
Recent Filings
51 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-09-23 | NSPR | Other (J) | — | $0 | EDGAR |
| 2026-05-29 | NSPR | Buy (P) | +20,000 | $17.5K | EDGAR |
| 2026-05-15 | NSPR | Buy (P) | +15,000 | $17.3K | EDGAR |
| 2026-05-13 | NSPR | Buy (P) | +75,626 | $88.0K | EDGAR |
| 2026-05-12 | NSPR | Buy (P) | +75,626 | $88.0K | EDGAR |
| 2026-05-08 | NSPR | Buy (P) | +7,895 | $9.0K | EDGAR |
| 2026-02-23 | NSPR | Buy (P) | +2,710 | $4.9K | EDGAR |
| 2026-01-16 | NSPR | Grant (A) | +132,076 | $0 | EDGAR |
| 2025-12-11 | NSPR | Buy (P) | +5,073 | $9.2K | EDGAR |
| 2025-12-08 | NSPR | Buy (P) | +5,073 | $9.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.